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Abstract
Anomalous self-assembly of the Ab peptide into fibrillar amyloid deposits is strongly correlated with the development of
Alzheimer’s disease. Ab fibril extension follows a template guided ‘‘dock and lock’’ mechanism where polymerisation is
catalysed by the fibrillar ends. Using surface plasmon resonance (SPR) and quenched hydrogen-deuterium exchange NMR
(H/D-exchange NMR), we have analysed the fibrillar structure and polymerisation properties of both the highly aggregation
prone Ab1–40 Glu22Gly (Ab
40Arc) and wild type Ab1–40 (Ab
40WT). The solvent protection patterns from H/D exchange
experiments suggest very similar structures of the fibrillar forms. However, through cross-seeding experiments monitored
by SPR, we found that the monomeric form of Ab
40WT is significantly impaired to acquire the fibrillar architecture of Ab
40Arc.
A detailed characterisation demonstrated that Ab
40WT has a restricted ability to dock and isomerise with high binding
affinity onto Ab
40Arc fibrils. These results have general implications for the process of fibril assembly, where the rate of
polymerisation, and consequently the architecture of the formed fibrils, is restricted by conformational constraints of the
monomers. Interestingly, we also found that the kinetic rate of fibril formation rather than the thermodynamically lowest
energy state determines the overall fibrillar structure.
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Introduction
Alzheimer’s disease (AD) is the most common form of dementia
today and results in both individual suffering and major
economical costs for society [1]. Development of AD is strongly
correlated to aggregation and amyloid formation of the 38–43
residue long amyloid-b peptide (Ab). Ab peptide is derived via
sequential cleavages of the amyloid precursor protein (APP) by b-
and c-secretases and is a natively unfolded peptide having a high
propensity to aggregate into cross-b amyloid fibrils through a
nucleation-dependent mechanism. The reason why Ab peptides
detrimentally self-assemble into fibrils in certain individuals is
currently not well understood. In most AD cases, no underlying
factor for the development of the disease can be pinpointed.
However, within a small group of individuals with early onset
Alzheimer’s disease (EOAD), a Mendelian inheritance has been
observed [2]. For most of these cases, a genetic anomaly results in
an enhanced processing of APP followed by increased Ab levels,
ultimately resulting in an increased rate of aggregation and fibril
formation [3]. In a few cases of EOAD, the phenotype has been
linked to a mutation within the Ab sequence of the APP gene
resulting in a gain of function where increased aggregation is
observed. The Ab Glu22Gly mutation was identified in northern
Sweden and is frequently denoted as the Arctic Ab variant,
Ab
40Arc. This mutation is associated with an aggressive form of AD
[4,5,6]. Ab Glu22Gly has a very high propensity for aggregation
and an enhanced ability to form protofibrils that have been shown
to be cytotoxic in both cell culture and transgenic animals
[5,7,8,9,10,11,12,13].
Amyloid polymerisation is a complicated process where
monomers are incorporated into the amyloid fibril form in
several steps. The polymerisation process has been studied in
detail and it is widely accepted that the process involves a dock
and lock mechanism [14]. The accepted model involves an initial
docking step that is followed by an affinity maturation reaction
through an isomerisation phase resulting in adjustment into a
conformation with higher binding strength. The model has been
further developed into 3 steps based on a dock, lock and block
mechanism where an initial weak association is followed by a
time dependent maturation phase with a concomitant increase in
binding affinity [15]. As each subunit is incorporated, a novel
recognition site is created and subsequent binding of additional
peptides blocks dissociation. This polymerisation phenomenon
can be conveniently monitored using surface plasmon resonance
(SPR) where pre-formed fibrils are immobilised and polymerisa-
tion is monitored through the addition of monomeric Ab peptides
[15,16,17,18].
Within this work we can show that the architecture of Ab fibrils
is determined by constraints imposed by the monomer conforma-
tion during docking and isomerisation. This finding has general
implications and suggests that although Ab is considered to be
unstructured it is restrained to adopt certain conformations which
impair its ability to acquire certain fibrillar structures. Interest-
ingly, our results moreover show that the kinetic rate of fibril
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e25157formation determines the fibrillar architecture rather than the
thermodynamically lowest energy state.
Materials and Methods
Preparation of monomeric peptide and fibrillar samples
All peptides were obtained from Alexotech AB, Umea ˚, Sweden
(www.alexotech.com). Due to the aggregation properties of Ab-
peptides, an appropriate solubilisation scheme was essential. Prior
to use, lyophilised peptides were solubilised in 10 mM NaOH at
pH 12, followed by 30 s sonication in a water bath and 5 min
centrifugation at 20 000 g to remove residual oligomeric species.
This treatment efficiently monomerised the peptides and facilitat-
ed dilution in phosphate buffered saline (PBS, 15 mM phosphate
buffer, pH 7.4, 150 mM NaCl) to the selected concentrations. All
samples were verified to have pH 7.4 or a pD corresponding to 7.0
by direct pH meter reading. Fibrillar forms were acquired by
incubating 100 mMA b at 37uC under agitation for 48 hours. m.
H/D exchange and NMR analysis of Ab
40WT and Ab
40Arc
fibrils
The fibrillar forms of
15N-Ab
40WT and
15N-Ab
40Arc were
prepared as described above. Fibrils composed of
15N-Ab
40Arc
were also prepared by cross-seeding using 15% (w/w)
14N-Ab
WT40
fibrils as seeds. Agitation was omitted during cross-seeding
experiments.
To probe solvent accessibility, aggregate/fibrillar solutions of
each peptide type were split into two fractions and recovered by
short centrifugation at 20 000 g. Hydrogen-deuterium (H/D)
exchange was carried out on one of the fractions by diluting the
pellets 30 times using a D2O solution (20 mM Tris, 150 mM
NaCl, pD 7.0) followed by 24 h incubation at 37uC. The second
fraction was used without further treatment as a fully protonated
reference sample to identify and exclude amide exchange resulting
from the experimental procedure (i.e. highly exposed amides
within the monomeric state). At the end of the incubation period
and immediately prior to NMR analysis, Ab assemblies were
recovered by short centrifugations (20 000 g) and rapidly
converted into NMR-detectable monomers using an optimised
solution of hexafluoroisopropanol as described previously [19].
Hydrogen exchange was subsequently monitored by recording a
series of heteronuclear 2D
15N-HSQC experiments, typically
starting 6–8 minutes after fibril dissolution. All experiments were
performed at 15uC on a 600 MHz Bruker AVANCE spectrom-
eter, equipped with a 5 mm triple-resonance, pulsed-field z-
gradient cryoprobe. The acquisition time for each
15N-HSQC
experiment was 10 min using four transients per increment and
128 (t1)61024 (t2) complex data points. Prior to each
15N-HSQC
experiment, a 1D proton NMR spectrum was acquired to
quantitatively monitor the dissolution of fibrils into monomers.
Protection ratios and experimental errors were determined as
described previously [19,20,21,22,23,24,25].
Surface plasmon resonance (SPR)
The different Ab variants, including both monomeric and
fibrillar, forms were immobilized at 10 mM peptide concentration
to a final density corresponding to 2000–5 000 RU to a CM5 chip
or to the dextran free chip C1 (GE Healthcare) using standard
amine-coupling chemistry at pH 5. Briefly, to activate the chip a
50/50 mixture of EDC (N-(3-dimethylaminopropyl)-N9-ethylcar-
bodimidehydrochloride) 0.4 M and NHS (N-hydroxysuccinimide)
0,1 M for 7 min.
After immobilization the chip was inactivated with a 7 min
injection of etanolamine 1 M.
Analysis of monomeric Ab binding to fibrils was performed at a
flow rate of 20 ml/min in PBS at 25uC. Important to note is that
the SPR signal is affected by the physical distance of the analyzed
interaction and the chip-surface. Due to the intrinsic nature of a
polymerising reaction the distance between the fibrillar ends and
the surface will increase during the reaction. Upon extended
polymerisation this results in a decreasing SPR signal and a non-
linear response. This effect was in detail monitored and to avoid
the problem of a non-linear dependency, fibrillar extension was
kept at a minimum, using short injection times in combination
with low peptide concentration, well within the range where a
non-linear curvature becomes pronounced.
According to standard procedures all sensograms were correct-
ed for non-specific interactions to a reference surface, and by
double referencing [26]. Regarding a subsequent analysis of the
fibril morphology Ab fibrils were immobilized to 1000RU on a C1
chip followed by injection of monomeric Ab allowing the fibrils to
grow to at least 3000RU. The SPR chip was then dissembled and
directly analyzed using AFM as described below.
Affinity determination between free peptide and the
amyloid fiber using SPR
Measurements of binding affinities between free monomers and
an amyloid fibril is not straight forwards since saturation of
monomer binding cannot be reached. However, since the
concentration of fibrils is constant during polymerisation, the
monomer dissociation constant will be equal to the free
concentration (critical concentration) of monomers at equilibrium.
Therefore, the dissociation constant can be used in combination
with SPR data obtained with known concentrations of peptides in
the running buffer to determine the affinity between the
monomers and fibrillar ends [27,28]. Fibril extension of Ab was
initiated through injection of 2 mM onto preformed immobilized
fibrils at a flow rate of 20 ml/min in PBS at 25uC for in total 30 s
followed immediately by various injection of 0–400 nM Ab
solution using the feature COINJECTION. The specific concen-
tration of Ab in the second injection that produced a linear plateau
response (no dissociation observed) represent the critical concen-
tration for polymerisation and consequently also the binding
constant.
Atomic force microscopy (AFM) analysis
Fibrillar samples were analysed directly on the surface of C1
chips (GE Healthcare, Uppsala, Sweden) that do not have a
dextran surface. Analysis was performed using a Nanoscope IIIa
multimode AFM (Digital Instruments Santa Barbara, USA) in
tapping mode
TM in air. A silicon probe was oscillated at around
280 kHz and images were collected at an optimised scan rate
corresponding to 1–2 Hz.
Results
Fibrillar core analysis using quenched H/D exchange
NMR
To evaluate whether there are any structural differences
between the fibrillar cores of Ab
40Arc and Ab
40WT, their
corresponding fibrillar form were analysed through quenched
H/D exchange NMR experiments. Figure 1a and 1b illustrates the
solvent protection of the core structure of Ab
40Arc and Ab
40WT,
respectively. The result clearly shows that no significant difference
can be identified between the two forms, only a slightly lower
protection is observed for the four C-terminal residues of Ab
40WT.
Figure 1c illustrates the H/D exchange pattern acquired from
Ab
40Arc when seeded with Ab
40WT fibrils and further strengthen
Ab Fibril Formation
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backbone structure, apart from a moderate reduction of the
solvent protection at the mutation site of Ab
40Arc.
Fibril polymerisation of Ab
40WT and Ab
40Arc monitored by
SPR
Surface plasmon resonance (SPR) enables the changes in bound
mass to a surface to be monitored and therefore provides a
convenient tool to follow fibril formation. Immobilised Ab
40WT
fibrils recruited free Ab
40WT monomers by a fibrillar polymerisa-
tion process (Fig. 2a). Binding sensograms hence displayed an
association phase immediately upon injection of monomeric Ab
peptides as a result of a continuous polymerisation, followed by a
dissociation phase at the end of each injection. The same result
was observed for immobilised fibrils of Ab
40Arc and free Ab
40Arc
monomers (Fig. 2b). To further examine the intermolecular
interactions between Ab
40WT and Ab
40Arc, cross-seeding experi-
ments were also performed. Interestingly, only a very slow
polymerisation was observed upon exposing monomeric Ab
40WT
to Ab
40Arc fibrils accompanied by a more rapid dissociation phase
(Fig. 2c). In contrast, Ab
40Arc monomers were easily recruited by
Ab
40WT fibrils and not accompanied with an increase in
dissociation rates (Fig. 2d). The effects on polymerisation and
dissociation rates for Ab
40WT monomers persisted even after cross-
seeding with Ab
40Arc/Ab
WT40 fibrils suggesting that it is the
fibrillar architecture rather than a sequence specific effect that is
causing this effect (data not shown). As a consequence, two
different fibrillar architectures can be anticipated where Ab
40Arc
monomers can more easily polymerise onto either fibrillar form
than Ab
40WT monomers.
Immobilised monomeric Ab on the chip surface could not
recruit monomeric variants from the solution, probed in an
identical manner as described above. This important control
verified the specificity of the system and also highlights the
dependency of a specific structure for an efficient peptide assembly
(data not shown).
Ultra-structure of Ab
40WT and Ab
40Arc fibrils
An SPR chip without dextran (C1, GE Healthcare, Uppsala
Sweden) was employed to compare Ab
40WT and Ab
40Arc fibril
morphologies and verify preservation of fibril integrity during
immobilisation on the SPR chip. Sonicated fibrils of Ab
40WT or
Ab
40Arc were immobilised followed by a continuous polymerisa-
tion. The surface of the C1 chips were directly analysed using
AFM (Fig. 3). The predominant fibrillar morphology had a
diameter of 5 nm but all samples also contained thinner filaments
of 3 nm diameter. No significant differences in morphology
between the different samples were observed.
Ab
40Arc displays stronger binding to fibrils than Ab
40WT
The critical concentration of free monomers at equilibrium was
determined by SPR using a co-injection technique where the
dissociation phase is monitored and modulated after monomer
injection by varying the concentrations of monomer in the running
buffer during the decay phase [29]. The KD50 for monomeric
Ab
40WT and Ab
40WT fibrils was determined to be 200 nM (Fig. 4a).
This result is consistent with a previous report [29]. The KD50 for
monomeric Ab
40Arc and Ab
40Arc fibrils was slightly higher
(100 nM, Fig. 4b). Surprisingly, binding of monomeric Ab
40Arc
to Ab
40WT fibrils had the strongest interaction with a KD50 value
of 50 nM (Fig. 4c).
Docking and isomerisation of Ab
40Arc is enhanced
The finding of an impaired ability for of Ab
40WT to adopt the
fibrillar architecture of Ab
40Arc fibrils implies an energetic barrier.
According to the principle of a template- dependent dock and lock
mechanisms, the locking of a peptide cannot efficiently occur
unless the previously loaded peptide has assembled into the correct
position [14,15]. A scenario where locking of the peptide (i.e.
affinity maturation), is the rate limiting step would be pronounced
at higher peptide concentrations and decrease at lower concen-
trations peptide concentrations. The concentration dependence of
fibril polymerisation was hence investigated to determine if peptide
locking is a rate limiting step. A clear difference in association rates
was observed when different concentrations of monomeric
Ab
40WT were polymerised with Ab
40Arc or Ab
40WT fibrils
(Fig. 5a). However, the relative difference in association rate was
not reduced at lower concentrations upon comparing the two
different systems. This can be seen as a linear dependence of the
association rate versus different concentrations. A system where
the isomerisation rate is rate limiting would result in a non-linear
curve. This indicates that a prolonged isomerisation phase, as a
result of lower monomeric concentrations, did not diminish the
effect on association rates. Regarding the interaction between
Ab
40WT monomers and Ab
40Arc fibrils the rate of assembly could
Figure 1. Solvent protection ratios for backbone amide
protons as determined by quenched H/D exchange monitored
by NMR spectroscopy. Protection is defined as the ratio of the
observed signal intensity after a 24 h pre-incubation period in D2Ot o
the signal intensity in a completely protonated reference sample.
Protection in the reference sample is defined as 100%. Circles
correspond to residues with 0% protection and crosses to residues
where exchange was too fast for detection. Pale grey bars indicate
overlapping residues with ambiguously assigned protection ratios. Error
bars indicate the experimental uncertainty given by the measurements.
(A) Ab
40Arc fibrils, (B) Ab
40WT fibrils, and (C) Ab
40Arc seeded with Ab
40WT
fibrils.
doi:10.1371/journal.pone.0025157.g001
Ab Fibril Formation
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the concentration corresponding to the KD of the interaction is
reached. Although the KD value for the interaction between free
Ab
40WT monomer and Ab
40Arc fibrils could not be determined as
the signal to noise ratio was too low this a higher KD value is
supported by an increased level of dissociation (Fig. 2c) suggesting
looser interactions and a competing back-reaction during the
isomerisation step.
A competition study was moreover carried out to investigate the
different docking abilities of Ab
40WT and Ab
40Arc monomers on
Ab
40Arc fibrils (Fig. 5b). The results indicate that Ab
40WT
monomer docking cannot compete with Ab
40Arc monomer
docking onto Ab
40Arc fibrils, indicating an impaired ability of
Ab
40WT to dock with Ab
40Arc fibrils. The decay rate is however,
affected suggesting that a fraction of incorporated Ab40
WT
significantly interferes with the overall stability of the fibril.
Discussion
To fully understand the self-assembly of Ab fibrils with the
ultimate goal of inhibiting Ab formation as a treatment for AD, it
is important to characterise both the fibril structural architecture
and the mechanisms of fibril formation. The intrinsic properties of
amyloid fibrils make a detailed molecular characterisation
technically challenging and the classical methods for structural
elucidation, such as X-ray crystallography and solution NMR,
cannot be directly applied. We have therefore developed a
methodology based on quenched H/D exchange combined with
Figure 2. SPR study of fibril elongation. Pre-formed Ab fibrils were immobilised on a CM5 chip and probed with 2 mM monomeric Ab for 1 min
at a flow rate of 20 ml/min in PBS at 25uC. (A) Monomeric Ab
40WT seeded with Ab
40WT fibrils, (B) monomeric Ab
40Arc seeded with Ab
40Arc fibrils, (C)
monomeric Ab
40WT seeded with Ab
40Arc fibrils, and (D) monomeric Ab
40Arc seeded with Ab
40WT fibrils.
doi:10.1371/journal.pone.0025157.g002
Figure 3. AFM analysis of fibrils immobilised on a C1 chip. Mature fibrils were briefly sonicated prior to immobilisation on C1 chip followed by
continuous polymerisation with free monomers until the total mass doubled. (A) Monomeric Ab
40WT seeded with Ab
40WT fibrils, (B) monomeric
Ab
40Arc seeded with Ab
40Arc fibrils, and (C) monomeric Ab
40Arc seeded with Ab
40WT fibrils. Scale bar is 0.5 mm.
doi:10.1371/journal.pone.0025157.g003
Ab Fibril Formation
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Ab fibril assemblies. The method quantitatively identifies the
residues involved in the fibrillar core [19,20,21,22,23]. Using
solvent protection analysis, we can conclude that the fibrillar
architectures of Ab
40WT and Ab
40Arc are strikingly similar, with
only minor differences for residues at the mutation site and the C-
terminal end. However, detailed analysis of the fibril formation
kinetics showed that Ab
40WT and Ab
40Arc fibril types differ in their
ability to template a polymerisation reaction.
The results presented here from cross-seeding experiments show
that monomeric Ab
40Arc cross-reacted easily with fibrils formed by
Ab
40WT. This is likely a result of the higher freedom of motion due
to the introduction of glycine at position 22. Ab
40WT was easily
incorporated within the fibrillar form of Ab
40WT but not Ab
40Arc.
Through kinetic analysis, we showed that Ab
40WT seeded on
Ab
40Arc exhibited a higher dissociation rate, indicating a
competing back-reaction where alternative conformations results
in increased dissociation of the monomer from the fibril. A
preceding cross-seeding event did not change the behaviour,
suggesting that the effect is a consequence of the fibrillar
architecture rather than the specific monomer sequence.
In the dock and lock model, the addition of a peptide onto the
fibrillar end is energetically unfavourable unless the previous
peptide has adopted the fibrillar conformation. This means that
prolongation of the maturation step (i.e. the time between
incorporation of two subsequent peptides onto the fibril) would
favour an increase in the fraction of high affinity bound peptides.
As a consequence, the time-dependent isomerisation event would
be enhanced at lower monomer concentrations where the time
between each new docking event would be longer, thereby
increasing the maturation time. However, our results showed that
the impaired ability of Ab
40WT to bind to the fibrillar form of
Ab
40Arc was not compensated for by lowering the monomer
concentration. This suggests that the affinity between Ab
40WT
monomers and the fibrillar end of Ab
40Arc is impaired. A direct
measurement of the association between free Ab
40WT monomers
and the fibrillar ends of Ab
40Arc was not possible due to a poor
signal to noise ratio. The significantly higher dissociation rate
noted upon probing Ab
40 on Ab
40Arc fibrils, however, suggests a
competing back-reaction and also a lower binding strength affinity.
Competition studies between monomeric Ab
40WT and Ab
40Arc
were performed as an alternative approach to evaluate the ability
of Ab
40WT to bind to the fibrillar form of Ab
40Arc. The results
showed that Ab
40WT monomers are essentially unable to interfere
with binding of Ab
40Arc to Ab
40Arc fibrils. However, Ab
40WT
monomers affected the dissociation rate. This could possibly be the
consequence of a small fraction of incorporated Ab
40WT
monomers introducing weak links in the Ab
40Arc fibrils. This is
consistent with a previous report where mixtures of Ab40
Arc and
Ab
40WT stabilised the oligomeric state of Ab
40Arc and thereby
prolonged its maturation into amyloid fibrils [30].
From our results, we can conclude that incorporation of
Ab
40WT monomers into the fibrillar form of Ab
40Arc is significantly
impaired as result of a reduced ability to dock and isomerise
relative to Ab
40Arc monomers. Upon docking, the fibril structure is
determined by a balance between intra-peptide and peptide-fibril
interactions. At this point, it is not possible to determine if the
impaired incorporation of Ab
40WT to adopt into Ab
40Arc fibrils is
due to structural limitations of monomeric Ab
40WT in solution,
interactions of the monomer with the fibril end or a combination
of the two effects. Nonetheless, Ab
40WT monomer binding to
Ab
40Arc is of low affinity and cannot compete efficiently with the
Ab
40Arc monomer binding. Therefore, the properties of Ab fibrils
are controlled to a great extent by the properties and constraints of
the precursor molecules.
From a general point of view, the initial formation of a nucleus
and the architecture of the resulting amyloid fibrils are controlled
by both thermodynamic and kinetic factors. As the aggregates
increase in size, the energetic barriers between different states
increases and kinetic barriers essentially block interconversion
between different fibrillar forms. On this basis we hypothesise that
the predominant fibrillar structure would be the structure with the
fastest kinetics of formation even though more thermodynamically
stable states might exist. Interestingly, this hypothesis is supported
by the results shown here as the measurements of affinity between
the monomers and the fibrillar ends are directly related to the
thermodynamic stability of the fibril [27,28]. Our results show that
Figure 4. Determination of the critical free concentration of Ab
required for fibril polymerisation. 2 mMA b solution was injected
for 30 s at a flow rate of 20 ml/min in PBS at 25uC. 100 mlo fA b (0–
400 nM) was then immediately injected. Measurements were carried
out to determine the critical free concentrations for (A) Ab
40WT
monomers with Ab
40WT fibrils, (B) Ab
40Arc monomers with Ab
40Arc
fibrils, and (C) Ab
40Arc monomers with Ab
40WT fibrils.
doi:10.1371/journal.pone.0025157.g004
Ab Fibril Formation
PLoS ONE | www.plosone.org 5 September 2011 | Volume 6 | Issue 9 | e25157Ab
40Arc monomers have a significantly stronger affinity for
Ab
40WT fibrils than Ab
40Arc fibrils. Since Ab
40Arc monomers can
adopt the conformation of both Ab
40WT and Ab
40Arc fibrils, it is
not thermodynamic stability that determines fibrillar architecture
but rather the rate of formation. Due to the high kinetic barriers, a
subsequent re-arrangement of the fibril into a thermodynamic
more stable form is prevented.
Development of AD is the consequence of an imbalance
between aggregate formation and degradation. The rate of peptide
assembly as well as the stability of the formed aggregates is
consequently of high importance. We can within this work show
that the solvent protection patterns of the fibrillar forms of Ab
40WT
and Ab
40Arc are similar and suggest a similar structure overall.
However, through cross-seeding experiments, striking differences
regarding aggregation rates was seen, indicating structural
differences. Our results suggest that Ab
40WT docking and
subsequent isomerisation into Ab
40Arc fibrils is restricted. This
finding highlights the importance of structural constraints at an
early point in the process of incorporating free monomers into Ab
fibrils. As a consequence, structural constraints of the monomer,
possibly already in solution, determine the rate of fibril assembly.
We further showed that formation of the predominant Ab fibrillar
architecture is controlled by kinetics rather than thermodynamics
where the most thermodynamically stable form is not necessarily
the predominant structure within a sample.
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